blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1

This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime http://www.opsi.gov.uk/acts/acts1997/ukpga_19970040_en_1



Saturday, 25 December 2010

Radagast - Matt Holford - abusive pharma blogger gives up

I've lost interest in the pharma thing: it's a fraud that nobody wishes to tackle... [shrug] It's not my problem, now: I've done as much damage to Big Pharma as it did to me, and that's where I'll leave it.



























https://www.blogger.com/comment.g?blogID=6605520130790875019&postID=1384652530508936078


check here for examples of his abuse to MHRA

http://bobfiddaman.blogspot.com/2010/12/seroxat-blogger-matt-holford-rulled.html

http://bobfiddaman.blogspot.com/2010/12/matt-holford-admits-seroxat-petition.html

Friday, 24 December 2010

L. Ron Hubbard had psychiatric medication in blood post mortem - vistaril (Pfizer)



source - http://www.xenu-directory.net/topics/hubbardsdeath.html

Matt Holford - 'mailing inane questions to the MHRA - sooner or later, somebody will be tempted into a response.."

I thought an update was due. I've been spending the past few days 'mailing inane questions to the MHRA, in the expectation that, sooner or later, somebody will be tempted into a response, whereupon I may start the interrogation! However, it's equally possible that they ignore me, as has my MP. I'll have to get my strike in early. I sometimes wonder if the more junior employees understand the nature of the business they're involved in.




Gosh, I do "Columbo" so well, it's almost a crime! But not quite. Like I wrote before, I'm unemployed, massively intelligent and in full command of every plan I wreck: what does one do with one's time, in the circumstances?


http://www.uncommonforum.com/viewtopic.php?t=25825&postdays=0&postorder=asc&start=30

Seroxat blogger Matt Holford rulled vexatious by MHRA who refuse to reply anymore

From: "MHRA Information Centre"


To: "Matthew Holford"

Subject: Reply

Date: Fri, 8 Jun 2007 15:24:25 +0100





Dear Mr Holford

Thank you for your email of 8th May. Please note that an applicant only has to demonstrate that the drug is more effective than a placebo and there is no requirement to demonstrate any scale of impact nor is there any requirement to show comparative benefits over any other type of treatment or other drug. It is the responsibility of NICE to advise prescribers on the comparative efficacy of treatments for a particular condition. The benefit of a particular drug is assessed by carrying out placebo controlled clinical trials in large numbers of patients. As I have pointed out to you before, summaries of these are published in the scientific literature in peer-reviewed academic journals and you can ask a library to conduct a literature search for these.



Thank you for copying the MHRA in on your correspondence with Mr Chapman of the ICO. It is apposite as we are refusing to reply to your emails of 22 May to Stephen Fawbert or your emails to the MHRA of 29th May, 31st May and 3rd June (and any other emails you may have sent or may send in the future on the same or substantially similar subjects), on the grounds that the requests have now become vexatious. Clearly, you feel that you have not had the answers you wanted to receive, but this is not the same as not being answered, and we have given such information as we are able, from what we actually hold. Consequently, there is nothing further we can add in this regard.



If you are unhappy with our decision, you may ask for it to be reviewed. That review will be undertaken by a senior member of the Agency who has not previously been involved in your requests. If you wish to pursue that option please write to the Communications Directorate, 10th Floor, Medicines and Healthcare products Regulatory Agency, at the above address.



After that, if you remain dissatisfied, you may write to the Information Commissioner
 
http://www.uncommonforum.com/viewtopic.php?p=348751

Matt Holford admits Seroxat petition response was "rather modest"

Hey Annie,


http://www.uncommonforum.com/viewtopic.php?p=348751


Thanks for your support (I should own up that my experience is with fluoxetine, rather than paroxetine, but, well, sue me!). I have to admit, also, that I'm a bit disappointed with the rather modest response to the petition, given that the much more moderate one, asking for an enquiry into licensing procedures, or somesuch, and started at the same time as mine, is well on its way to 300 signatures. I'm not that bothered, it just seems odd.



Sorry to hear about your experiences. The business over withdrawal is a very controversial one, as you know, with all kinds of dubious games of semantics being played (have you read the Expert Working Group's report on SSRIs - it's as dull as dishwater, but explains how it came to the conclusion that SSRIs aren't addictive!).



Anyway, if you fancy a laugh, drop in at Seroxat User Group, Seroxat Secrets, Seroxat Sufferers and GSK Licence to (K)ill, (by the Truthman), which are all eye-openers. It's a good bunch of people, who post there, and the network is rather wider than a few people who've suffered the adverse reactions, although the journalists, MPs, lawyers and scientists tend to keep a lower profile (except for Michael Moore)! We're deadly serious about this, but we know how to laugh at the ridiculousness of it all, too!



Muchel lufu



Matt

Paul Flynn MP - just another Seroxat liar

extract - http://www.paulflynnmp.co.uk/seroxat04.htm

The reaction from industry and regulators has been resentful and faltering. The UK Committee on Safety of Medicines in December 2003 banned the use of SSRIs except Prozac for under-18 year olds. The mother of a 17 year old girl who took her life on Seroxat asked a recent meeting in the Commons, ‘What is the difference between the brain of a 17 year old and a 20 year old.’ There is none.




The MHRA report on Seroxat was a lamentable document. If dealt with only the conclusions of the Pharmas’ controlled trails and not the data on which they are based.

Seroxat ban for children - just another lie from the Daily Mail

Seroxat ban for children
by ROSALIND RYAN, femail.co.uk


http://www.dailymail.co.uk/health/article-184196/Seroxat-ban-children.html

From: "Derek D Scott" - Seroxat withdrawal - latent mental illness - or untreated Klinefelter's syndrome ?

From: "Derek D Scott"


Date: Sun Oct 23, 2005 4:34 pm

Subject: RE: Seroxat User Group Re: derek seroxat_addict

Offline

Send Email



Agreed I have put a lot of time and effort into the group. But it’s the many other users who contribute to what makes the group what it is. A much needed support network, something the NHS doesn’t seem to appreciate. In a recent survey in the Guardian 95% of users sought help from online groups rather than their GP's. Their GP's were quick to prescribe an antidepressant but when it came to withdrawing them from it they were absolutely useless (they didn’t know how), and users then turned to online groups such as ours for help. Members of this group as a whole have a lot of experience to share and unlike the NHS or GP's know something they don’t or are unwilling to admit, Seroxat and many other antidepressants are defective and should not be prescribed. Cognitive Behavioural Therapy should be the first choice antidepressants being the last resort after all other avenues have been explored. I've already been referred to a cognitive therapist previously and found her of little benefit, but then she was a trainee, and the choice of therapy was the wrong one I should have been according to my consultant psychiatrist been provided with mindfulness cognitive therapy. I'm being referred to Ninewells Hospital Neurology department to determine how best to manage my mental illnesses. Like you say the group is only as good as the people who attend and post regularly, in some instances individuals can provide support to someone at their lowest ebb and who have been failed by the NHS which needs to be radically transformed from a useless service into one that caters for the needs of mental health users like ourselves.





Derek. Xx





http://www.bangor.ac.uk/mindfulness/ might be of interest to our Welsh members?



http://www.amazon.co.uk/exec/obidos/ASIN/1572307064/202-4401450-7961438

Wednesday, 22 December 2010

Paxil and Doxepin - probable cause statement reported murderer on the antidepressant medications

 Paxil and Doxepin

http://health.dir.groups.yahoo.com/group/SSRI-Crusaders/message/31694

"Ragsdale is being held without bail. The probable cause statement reported

Ragsdale is on the antidepressant medications Doxepin and Paroxetine, and
he may harm Kristy Ragsdale's mother or his children if he is released."



http://www.heraldextra.com/content/view/251050/3/

Lehi remembers slain mother




Janice Peterson and Cathy Allred - DAILY HERALD

Husband charged with aggravated murder



A Draper man accused of shooting his wife to death outside a church building in

Lehi has been booked in the Utah County Jail on a charge of aggravated murder.

Police say David Ragsdale, 35, opened fire on his estranged wife around 11 a.m.
Sunday morning as she arrived with her mother for church services at The Church
of Jesus Christ of Latter-day Saints meetinghouse at 1691 E. 900 North. Kristy
Ragsdale, who turned 30 on Sunday, was shot multiple times with a Glock 9mm
handgun and died at the scene

Paxil & Doxepin - murder judge dismisses Ragsdale malpractice lawsuit

Salt Lake judge dismisses Ragsdale malpractice lawsuit



Jim Dalrymple - Daily Herald Daily Herald
Posted: Tuesday, December 21, 2010 12:30 am
Loading…

http://www.heraldextra.com/news/local/article_c4d19972-5781-5753-9402-1b05a4055b8c.html?oCampaign=hottopics

Font Size:Default font sizeLarger font size.

ASHLEY FRANSCELL/Daily Herald David Ragsdale pleaded guilty to aggravated murder for killing his wife Kristy in January 2008 during a hearing Wednesday, November 26, 2008 in the Fourth District Court in Provo. .

Loading…

..A Salt Lake County judge dismissed a malpractice lawsuit on Monday against the former medical providers of convicted murderer David Ragsdale.



During a hearing, Judge Denise Lindberg of Utah's 3rd District Court sided against attorneys Allen Young and Tyler Young, who had filed a lawsuit against Trina West, a nurse practitioner, Dr. Hugo Rodier and Pioneer Comprehensive Medical Clinic. West, Rodier and the clinic provided health care and medication to Ragsdale prior to the killing of his wife, Kristy, on Jan. 6, 2008. Ragsdale was convicted of the murder in November 2008 and is currently serving 20 years to life in prison. Allen and Tyler Young had argued that the murder was a "foreseeable" result of a cocktail of psychotropic medications he had been prescribed. They were acting on behalf of attorney William Jeffs, the conservator of David and Kristy Ragsdale's children.



In May, West's attorney, Steven Owens, filed a motion to dismiss the case. Attorneys for Dr. Rodier and Pioneer Comprehensive Medical Clinic joined the motion in June. During arguments Monday regarding the motion, Owens said the court should not hold a health care provider liable for a client's criminal conduct when that provider has no custody or control over the client, and when the client has taken full responsibility for his actions. Judge Lindberg ultimately agreed, saying David Ragsdale's children didn't have the right to bring a lawsuit in this case.



Owens and Michael McKell, the attorney for Pioneer Comprehensive Medical Clinic, both said on Monday that their clients were happy with the ruling.



In the month before the shooting, Ragsdale was using seven different psychotropic medications, including Concerta, Valium, Doxepin, Paxil, Pregnenolone, Propecia and testosterone.



Allen Young and Tyler Young's lawsuit originally argued that Ragsdale's medications were a cause in the shooting, but not necessarily the sole cause. The suit alleged that West prescribed several different medications for Ragsdale in the nine months leading up to the shooting without properly consulting a licensed doctor. The suit also alleged that Rodier failed to consult with West. Allen and Tyler Young sought unspecified money and punitive damages, and said that the money would go to the Ragsdale children.



Allen and Tyler Young now have the option to appeal their case.



Related


•Malpractice suit filed on behalf of Ragsdale children

•David Ragsdale gets 20 years to life in prison in wife's murder

•David Ragsdale pleads guilty to killing his wife

•Ragsdale custody case settled

Seroxat - what Fiddaman doesn't tell his reader! - Canada class action refused Nov 2010 pdf version

PAXIL- GSK wins a major victory as class action is refused authorization

Pharmaceutical industry wins a major victory as class action is refused authorization


Ogilvy Renault LLP Marianne Ignacz and Anne-Louise Lamarre Canada


http://www.lexology.com/library/detail.aspx?g=4638c48c-af5b-414f-9943-5a30d7a8670d

December 13 2010

http://www.ogilvyrenault.com/en/resourceCentre_publications.aspx



. In a unanimous ruling[i] on November 12, 2010, the Quebec Court of Appeal maintained the dismissal of a motion for authorization to institute a class action against GlaxoSmithKline Inc. ("GSK").[ii] The petitioner, Iyana Goyette, sought to represent all persons residing in Canada who allegedly experienced dependency and withdrawal problems further to use of the antidepressant PAXIL®, claiming that GSK (i) had marketed the drug without assuring its safety, (ii) had breached its obligation to adequately inform health professionals and consumers of the risks of reducing or discontinuing its use, and (iii) had made false representations about such risks. Ms. Goyette claimed physical, economic, moral and punitive damages on behalf of members of the proposed group.



The Court of Appeal confirmed the Superior Court's finding that the criteria set out in paragraphs (a) and (b) of Article 1003 of the Code of Civil Procedure ("CCP") had not been satisfied.



BACKGROUND



It should be borne in mind that this proceeding was initiated prior to the 2003 reform of the CCP, at a time when it was still possible to file relevant affidavit evidence without authorization of the court. Thus, in support of its contestation, GSK was able to provide the court with information relevant to the criteria set out in Article 1003 by filing the examination of Ms. Goyette on her affidavit, together with an expert's affidavit. This documentary evidence showed that it would be necessary to examine the case of each member of the proposed group in order to determine whether he or she had suffered from the alleged symptoms and whether the symptoms were related to reducing or discontinuing use of PAXIL.



The examinations revealed that the petitioner had started to take PAXIL after consulting her doctor, who had examined the Compendium of Pharmaceutical Specialties (CPS) with her and had confirmed that there was no risk of dependency or withdrawal associated with discontinuing its use. In fact, the CPS described a variety of symptoms that might occur following cessation of treatment, characterizing them as "generally mild and transient," and indicated that withdrawal and dependency syndromes were "rare".



Article 1003(a) CCP - Existence of identical, similar or related questions of law or fact



The Court of Appeal concluded that the trial judge had not made any palpable or overriding error when he applied an important principle set out in Voisins du train de banlieue de Blainville inc. c. Agence métropolitaine de transport,[iii] namely, the need to establish collective prejudice in order to meet the test of Article 1003(a) CCP. The Court of Appeal found that the trial judge had ruled correctly in light of the allegations and the evidence presented, namely, that there could be no collective prejudice since the alleged subjective symptoms associated with the reduction or cessation of the drug, such as headaches, dizziness, vertigo or insomnia, were susceptible of infinite variations.



On appeal, Ms. Goyette pleaded that requiring proof of collective prejudice was contrary to the intention of the legislator, which had adopted Articles 1037 to 1040 CCP to deal specifically with individual claims. Relying on decisions where class actions were authorized in pharmaceutical matters, the petitioner argued that the individual assessment of the prejudice allegedly suffered by each member should be conducted in the context of the procedure contained in Articles 1037 to 1040 CCP. Her argument failed to sway the Court of Appeal.



Thus, breaking with all previous class action decisions in pharmaceutical matters, in which actions were authorized when the only common issue was one of fault, the Court of Appeal has recognized that the impossibility of proving collective prejudice is a bar to satisfying the test of Article 1003(a) CCP.



The facts alleged seem to justify the conclusions sought (Article 1003(b) CCP)



The Court of Appeal also agreed with the trial judge's finding that Ms. Goyette had failed to satisfy the colour of right test contained in Article 1003(b) CCP. Justice Peacock concluded that the allegation that GSK had failed to provide adequate information about the risks of discontinuing the drug was unfounded since the information disclosed in the CPS adequately described the risk of dependency and withdrawal. The Court of Appeal did not find any palpable or overriding error in the trial judge's appraisal of the evidence such as would warrant its intervention.



The Court of Appeal did not comment on Justice Peacock's decision to disregard evidence from other jurisdictions on grounds of irrelevance for purposes of the test in Article 1003(b) CCP.



Failure to represent adequately (Article 1003(d) CCP)



In light of its decision on Article 1003(a) and (b), the Court of Appeal did not comment on the trial judge's finding that Ms. Goyette was not an adequate representative because (i) she did not have a personal cause of action against GSK; (ii) she had shown a singular lack of interest in the class action; and (iii) she never sought to speak with any member of the group, knew none of them and had never sought to communicate with any of them.



National class



The Court of Appeal did not express an opinion on the trial judge's analysis of the conditions for authorization of a national class. Justice Peacock referred to the conditions laid down in the Civil Code of Québec for the Quebec courts to assume jurisdiction. They include the fact that the defendant has an establishment in Quebec and the dispute relates to its activities in Quebec or that damage is suffered in Quebec. Justice Peacock concluded that since Ms. Goyette had failed to demonstrate that the activities in issue were associated with a place of business in Quebec, even if he had authorized the class action, she could only have represented members resident in Quebec as only they could have proved damage suffered in Quebec.



CONCLUSION



In this case, the Court of Appeal agreed that the failure to prove collective prejudice made it impossible to satisfy the test contained in Article 1003(a) CCP, without considering whether the other conditions required to establish liability, such as fault or causation, could constitute a common issue. However, Justice Peacock maintained that fault and causation did not constitute common issues. In the circumstances, it may be argued that the common issue test provided in Article 1003(a) CCP cannot be met when a condition necessary to establish liability is susceptible of variations.



As a result of this decision, it will be difficult for a petitioner to argue that an individualized assessment should be conducted in accordance with Articles 1037 to 1040 CCP, which set out the procedure applicable to the determination of individual claims when a class action is granted on the merits.



Goyette c. GlaxoSmithKline Inc. shows that while the burden of proof at the authorization stage remains a burden of demonstration, it is nevertheless necessary to demonstrate a serious colour of right with respect to all the conditions required to establish liability in order to meet the test of Article 1003(b).



To view all formatting for this article (eg, tables, footnotes), please access the original here.

Tuesday, 21 December 2010

Not Lithium - Not Seroquel - Not nexium caused Susan's kidneys to fail

Update On Lithium Toxicity (I hope this will clear up any confusion)   


http://ifyouregoingthoughhellkeepgoing.blogspot.com/2010/12/update-on-lithium-toxicity-i-hope-this.html

There seems to be some miscommunication going around the blogosphere what caused my kidneys to fail. I fear I might have accidentally added to it.  



I saw the GP yesterday. Here is the official scoop, which I hope will end any confusion.



The official result that was sent to the insurance company is from "Unknown Etymology".

My GP told my mother he thinks it was from an over the counter pain pill I had taken 18 hours before for menstrual cramps. I took two pills, and in 18 hours they had left my system by then.



However the second time I was admitted to the hospital I spoke to several doctors and interns who actually took the time to sit down with me and go over the meds I have been on and said it was from lithium poisoning but they would never swear to that on the record.



I was premature when I blogged from my hospital bed it might have been from Nexium or Seroquel, the results from the biopsy had not come in and the doctors were just shooting theories at me, and I was desperate to tell people I am alive. NO RESULTS WERE KNOWN AT THE TIME BECAUSE THE BIOPSY GOT LOST AND IT TOOK TWO WEEKS TO GET THE RESULTS. When I spoke to another blogger on the phone two weeks ago, the biopsy had not come in. No one knew at the time what the official reason was.



So I admit I made a huge mistake in blogging what it might and might not have been. We learn from our mistakes and I am truly sorry for any confusion I might have caused. It was not my intent.



And for those who still might doubt me, at the time of my admission, there was only Seroquel and lithium in my blood stream. No other drugs. I take Nexium once a week. And there was the OTC pill I had taken for cramps 18 hours prior. I had taken the Nexium pill several days earlier, so it was not in my blood stream. Nexium did not show up on the biopsy. You can draw your own conclusions.



Again, I am sorry for any misconceptions that are going around the blogosphere. If there is any questions, please don't hesitate to email me at Hollythecat at gmail. com

I understand if anyone is angry at me because of this, It was not my intention.



I have stated the complete facts as they are totally known.



Sincerely,

Susan

MPs' expenses: Tory MP Jonathan Djanogly claimed almost £5,000 for automatic gates

MPs' expenses: Tory MP Jonathan Djanogly claimed almost £5,000 for automatic gates



http://www.telegraph.co.uk/news/newstopics/mps-expenses/5368993/MPs-expenses-Tory-MP-Jonathan-Djanogly-claimed-almost-5000-for-automatic-gates.html

Simmons - 16 years on, Jon is still dependant on anti-depressants - NOT Seroxat

extract from - Drug group campaigner to meet PM - Jonathan Djanogly MP






Mrs Simmons set up the group after seeing the addiction of her husband.


Six years before they met, Jon and his first wife were prescribed anti-depressants when their marriage broke down. Jon's wife committed suicide within three weeks of being  put on Prozac while 16 years on, Jon is still dependant on anti-depressants.


The Seroxat User Group will also remind Mr Brown that more support groups and funding are needed to help patients trying to withdraw from anti-depressants. "

http://www.jonathandjanogly.com/content/drug-group-campaigner-meet-pm

Amy Philo gets her CCHR award - next years stooge could be Bob Fiddaman

Sheila and Patty, along with Amy Philo, Mathy Downing, and Vicky Dunkle, received an “Outstanding Achievement Award for Children’s Rights,” in February 2009, at CCHR’s annual banquet,


http://www.cchrint.org/2010/11/18/ablechild%E2%80%94unsung-hero-in-battle-against-psychopharmaceutical-industry/

full report by Fiddy's mate Evelyn Pringle

Fiddamin needs some vitimin...Anonymous tag Fiddaman

Fiddamin needs some vitimin...


http://forums.whyweprotest.net/tags/bob/

Interesting stuff, will have to have a better look-see later, but interesting non-the-less.



If there are connections to CCHR etc. no doubt there probably are, just shows the 'high quality' of their experts once again. Think there are still a few of their so-called ones who are still trying to divest themselves from that bunch of coo-coo nuts.



The spider-web of CoS interests, fronts, and legitimising ploys is complicated and warped imho.

L Ron Hubbard Ordered the #Murder of Twelve Innocent People - #Scientology


source -
 
 
AnonymousZurich RT @Misanthropique-RT @AnonUK: #Scientology Founder L Ron Hubbard Ordered the #Murder of Twelve Innocent People. http://dld.bz/5u8s #...

10% of adults 'on antidepressants' - Scotland -

10% of adults 'on antidepressants'


(UKPA) – 1 hour ago



One in 10 adults in Scotland are thought to be on antidepressants, according to official figures.

The volume of prescribed medicines increased by 7.6% in a year, from 4.01 million items in 2008-9 to 4.31 million items in 2009-10.

Statistics published by health service data collection body ISD Scotland showed the total has increased from 2.77 million 10 years ago. The Scottish Government had set a target to stop the rise by 2009-10 and prepare the ground for a 10% reduction in future years.

Copyright © 2010 The Press Association. All rights reserved.

http://www.google.com/hostednews/ukpress/article/ALeqM5iVd65iHHnE6sv_8WY6MMzrV9QqdA?docId=N0264411292936818082A

Kelly Patricia O Meara can't even spell Andy Vickery's name - so why would you believe anything else this "journalist" claims

http://www.prozactruth.com/article_british_ban_spur_fda.htm

Andy Vickory of the Houston law firm of Vickory and Waldner has spent nearly a decade representing families who believe they have been harmed by SSRIs. He was the lead attorney in a landmark decision in the 2001 case of Donald Schell, a retired oil-rig worker who had taken Paxil for just two days when he shot and killed his wife, daughter and granddaughter before turning the gun on himself. The jury in the Schell case found that Paxil, made by GlaxoSmithKline, "can cause some individuals to commit suicide and/or homicide" and awarded the surviving family members $8 million in damages.




Vickory tells Insight, "I'm pleased with the decision in the U.K., but I don't see anything coming from the FDA. I think they're going to stall. I've devoted the last eight or 10 years of my life to this issue and no telling how many years of my life trying to make every effort to understand these issues so ordinary people can understand what's at stake. And now I've been told by the FDA that I'll get just three minutes before the committee. There's not a whole hell of a lot you can say in three minutes about such an important issue."



Although Vickory is hopeful about the United Kingdom's decision on the SSRIs, he is openly confused about the panel's decision on Prozac. "It is astonishing," says Vickory, "that the U.K. didn't ban Prozac. There was an article in the British Journal of Psychiatry about a large-scale study - some 2,770 or so patients - on SSRIs. And what they found was that fluoxetine [Prozac] has the highest risk of deliberate self-harm. The study shows that if you take Prozac you are 6.6 times more likely deliberately to harm yourself. So why in the face of that data the U.K. would ban all other SSRIs but not Prozac is astounding. The answer for public consumption is that none of the other drugs being considered by the U.K. even showed any efficacy. My response to the British would be, 'Okay, if that's your decision, since you know it also triggers suicide in some, at least make the manufacturer put a warning label on it.'"